Point of Care Immunoassay Drugs of Abuse Screening in a Post Mortem Population
International Journal of Forensic Science & Research · 2025
DOI: 10.33425/3066-3830.1008 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Forensic Science & Research, 2025. Verfasst von Hartel Paul und 5 weiteren Autor:innen.
Abstract (Originalsprache)
To test the utility of point-of-care immunoassay testing of drugs of abuse in a post-mortem population, we compared immunoassay near-body drugs of abuse results with liquid/gas chromatography-mass spectrometry confirmatory testing. While immunoassay results are subject to false positives from decompositional amines and prescription medications, negative screening tests can produce significant cost-savings and allow for timelier autopsy reports where confirmatory testing is unnecessary. This would also help ease the burden on reference and/or State laboratories and save approximately 500,000 euros per annum across the health system.
Zitieren
APA
Paul, H., Sinead, O., Liam, O., Louise, M., John, C., & Geraldine, D. (2025). Point of Care Immunoassay Drugs of Abuse Screening in a Post Mortem Population. International Journal of Forensic Science & Research. https://doi.org/10.33425/3066-3830.1008
Vancouver
Paul H, Sinead O, Liam O, Louise M, John C, Geraldine D. Point of Care Immunoassay Drugs of Abuse Screening in a Post Mortem Population. International Journal of Forensic Science & Research. 2025. doi:10.33425/3066-3830.1008
BibTeX
@article{Paul2025,
author = {Paul, Hartel and Sinead, O’Connell and Liam, O’Grady and Louise, Molloy and John, Cassella and Geraldine, Dowling},
title = {Point of Care Immunoassay Drugs of Abuse Screening in a Post Mortem Population},
journal = {International Journal of Forensic Science & Research},
year = {2025},
doi = {10.33425/3066-3830.1008}
}
EUVIMED